Average results — up to twice as long as Botox. Fewer appointments, same natural wrinkle reduction.
Daxxify® (daxibotulinumtoxinA-lanm) is the newest FDA-approved botulinum toxin type A treatment, uniquely engineered for extended duration. Clinical studies show results lasting an average of 6 months, with some patients maintaining results up to 9 months — significantly longer than Botox or Xeomin.
Daxxify uses a proprietary peptide stabilizer instead of human serum albumin or animal-derived proteins, making it the first peptide-powered neurotoxin of its kind. At Bluewater, Daxxify is offered as part of our full injectable menu alongside Botox and Xeomin, administered by Michelle Sasala, ARNP-BC.
Daxxify consistently outperforms other neurotoxins in clinical duration. Here's how the products compare on average:
Individual results vary. Your injector will set realistic expectations during your consultation based on your individual history with neurotoxins.
Daxxify may be an excellent choice if you:
During your consultation, your injector will review your history, discuss your goals, and recommend the product — Botox, Xeomin, or Daxxify — that best fits your needs and lifestyle.
Your injector reviews your history and goals, confirming whether Daxxify is the right fit for your needs.
10–20 minutes. Fine needle injections, similar in feel to Botox. Minimal discomfort.
None. Avoid strenuous exercise and alcohol for 4 hours. Return to your normal day immediately.
Onset 2–5 days, full effect at 2 weeks. Average duration 6 months, up to 9 months.
Michelle Sasala, ARNP-BC, administers all neurotoxin treatments with the clinical experience needed for precise, natural-looking results.
We offer Botox, Xeomin, and Daxxify — so your recommendation is always based on your individual needs, not a single product.
All injections are performed in a clinical medical environment with full oversight — ensuring safety and accuracy at every appointment.
Both are botulinum toxin type A treatments. Daxxify uses a peptide stabilizer instead of albumin, and its clinical data shows a significantly longer average duration — approximately 6 months versus 3–4 months for Botox. Daxxify is also formulated without animal-derived proteins, making it vegan-friendly.
Yes. Daxxify received FDA approval in 2022 for the treatment of moderate to severe glabellar (frown) lines in adults. It is manufactured by Revance Therapeutics.
The per-treatment cost of Daxxify may be higher than Botox, but because it lasts longer, many patients find the overall annual cost comparable when accounting for fewer appointments. Your injector will provide a personalized estimate at your consultation. See our Non-Surgical Pricing page for reference.
Daxxify is FDA-approved specifically for glabellar (frown) lines. Clinical use has expanded to other commonly treated neurotoxin areas. Your injector will discuss what's appropriate for your goals during your consultation.
Request an appointment online or call us at (850) 530-6064. Our team will confirm whether Daxxify is the right choice for you and schedule your treatment.
